3827 results for «2021»
3827 results
Practical solutions to grow your TAVI programme - peer-to-peer case sharing
23 Nov 2021 – From PCR London Valves 2021
Thanks to this PCR London Valves 2021 session, explore real-world examples of how to use digital communication successfully with your referral network, discover practical ways to implement a TAVI nurse programme in your hospital and learn how to obtain resources and support from your hospital management...

Closing Ceremony
23 Nov 2021 – From PCR London Valves 2021
Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...

Coronary physiology in STEMI: is OpSens OptoWire III a game-changer in complete revascularisation?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Engstrom, Zsolt Piroth, Jacques Monsegu and Giuseppe Biondi-Zoccai in order to get an update on the latest evidence in physiology-guided full revascularisation in STEMI patients, to discover how the innovative physiology wire, OptoWire III from OpSens may lower the barriers to approach...

Redefining hypertension management with renal denervation
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jeffrey Popma, David Kandzari, Felix Mahfoud and Andrew Sharp in order to understand the latest data on the safety and efficacy of radiofrequency renal denervation including future studies, to learn about the long-term durability of renal denervation in a real-world patient population, and...

Endovascular aortic repair and case-based discussion of complications during peripheral interventions (Part 2)
20 May 2021 – From EuroPCR 2021
This session, which was originally broadcast during EuroPCR 2021, presents 6 cases of unexpected complications of large vessel access in the context of TAVI procedures and enables our experts to discuss their successful management, using a variety of techniques. It highlights the need for a large...

Mastering multi-modality imaging for transcatheter valve interventions with chamber views and S-curves
20 May 2021 – From EuroPCR 2021
Thanks to this session, originally presented during EuroPCR 2021, get proved that chamber views can be appreciated across all cardiovascular imaging modalities, discover how important chamber views and S-curves can be for transcatheter valve interventions, and learn why chamber views can enhance joint work between interventional cardiologists...

Best of the European Heart Journal
19 May 2021 – From EuroPCR 2021
Watch this session, originally presented during EuroPCR 2021 by F. Crea, Editor-in-chief, and C. Berry, Executive Editor, to find out more, both about the most cited European Heart Journal original research article, and the most Almetric scored one, and enjoy in-depth analysis of the SOLVE-TAVI and DAEDALUS studies in...

Improving your patient's outcomes with the Edwards Benchmark program
18 May 2021 – From EuroPCR 2021
Watch this session presented by Hélène Eltchaninoff in order to understand the benefit of delivering a standardised care pathway to consistently achieve excellent outcomes, to improve access to high quality of care with safe early discharge for selected patients, in Europe, and to learn how the Edwards Benchmark...

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension
18 May 2021 – From EuroPCR 2021
Watch this session presented by Andrew Sharp in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...

RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Atul Pathak in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...

EBC MAIN overview and the impact on clinical practice
18 May 2021 – From EuroPCR 2021
Watch this session presented by David Hildick-Smith, Jens Flensted Lassen and Goran Stankovic in order to learn more about this important study and understand the impact to clinical practice, to gain insights from an interesting EBC main case, and to listen to the expert's perspectives on other recent...

Addressing diabetes globally with an innovative solution
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Luca Testa and Alexandre Abizaid in order to understand the need to address diabetes with a dedicated solution, to learn how the DES+DCB platform can help counter DM in PCI, and to get insights into the ongoing and upcoming clinical programs.
View...

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...

New, novel Navitor TAVI valve with active paravalvular leak-sealing technology
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard to learn about the latest TAVI active PVL-sealing technology, to understand the clinical evidence with the active PVL-sealing technology, and to discuss the value that the new, novel Navitor valve brings in today's TAVI market.
View the recording of this EuroPCR 2021 Session...

Single vs. two-stent techniques in left main: the impact of EBC MAIN
18 May 2021 – From EuroPCR 2021
Watch this video presented by Goran Stankovic, Tom Johnson, David Hildick-Smith, Jens Flensted Lassen, Gabor G. Toth and Junjie Zhang in order to understand the results of EBC MAIN and the impact to clinical practice, to discuss the EBC MAIN outcomes of one- vs. two-stent technique, and to hear...

Introducing Navitor: a new TAVI solution
18 May 2021 – From EuroPCR 2021
Watch this session presented by Helge Möllmann, Lars Sondergaard, Maurizio Taramasso, Ganesh Manoharan and Dave Smith in order to discuss how to minimise resources needed for your TAVI procedure without compromising safety and efficacy, to demonstrate how to simplify your TAVI procedure, and to examine considerations for lifetime management of your...

Renal denervation in the real-world: performance in high risk subgroups
05 Oct 2021 – From AICT-AsiaPCR 2021
After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...

We Care: a joint initiative PCR & Stent – Save a Life!
18 May 2021 – From EuroPCR 2021
In line with its commitment to serving the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice, and inspired by the challenging global pandemic of COVID-19, PCR is proud to have joined up with Stent – Save a Life!...

Complete revascularisation in patients with acute myocardial infarction
18 May 2021 – From EuroPCR 2021
Watch this session presented by Piroth Zsolt in order to get a quick update on the latest most significant evidence in physiology guided PCI in patients with acute MI, to have a recommendation from an expert on how this assessment can be implemented today compatibly with a IIa...

Clinical event reductions in high-risk hypertension patients treated with renal denervation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...
